Recent News & Comments About metformin weight loss
Metformin And Rosiglitazone Combo Best For Kids With Diabetes Type 2
Controlling blood sugar in children and teenagers with diabetes type two is best achieved with a metformin plus rosiglitazone combo, compared to just metformin or metformin plus lifestyle changes, researchers reported in NEJM (New England Journal of Medicine). Blood-sugar control is also known as glycemic control, or blood glucose control. There are very limited reliable data to guide treatment ...
Weight-Gaining Drugs
About 70 percent of people in the United States are overweight and, in a cruel catch-22, many of the drugs used to treat obesity-linked conditions such as diabetes, high blood pressure, and depression can themselves cause weight gain.
Novel plant blend could be a game changer in fight vs metabolic syndrome, claim inventors
Developed by ATM Metabolics co-founders Dr Daryl Thompson and Dr Joseph Ahrens, Emulin is a patented blend of plant-sourced chlorogenic acid, myricetin and quercetin they claim could turn the tables in the fight against metabolic syndrome by helping to maintain healthy blood sugar levels and promoting weight loss.
Type 2 Diabetes in Kids a Challenge to Control
Title: Type 2 Diabetes in Kids a Challenge to Control Category: Health News Created: 5/1/2012 11:01:00 AM Last Editorial Review: 5/1/2012 12:00:00 AM
Combo Treatment Tops for Diabetic Kids
A combination of metformin and Avandia is best for controlling blood sugar in kids with type 2 diabetes.
Diabetes type 2 in adolescents: Catch-22 in 2012
On April 31, 2012 the evening major news networks highlighted the dismal failures of controlling type 2 diabetes in our USA adolescents by reviewing the recent study entitled: A Clinical Trial t...
Two drugs better than one to treat youth with type 2 diabetes, study suggests
A combination of two diabetes drugs, metformin and rosiglitazone, was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a new study has found. Adding an intensive lifestyle intervention to metformin provided no more benefit than metformin therapy alone.
Depomed Reports First Quarter Financial Results
MENLO PARK, Calif., May 8, 2012 /PRNewswire/ -- Depomed, Inc. (DEPO) today reported financial results for the quarter ended March 31, 2012.2012 First Quarter Business HighlightsFinancial Highlights:Revenue ...
Obesity-Linked Diabetes Tougher to Treat in Children
Type 2 diabetes is harder to treat in children ages 10 to 17 than it is in adults, according to one of the first large studies of the disease in younger people.
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting
Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the inv
 |
|
Free Diet Articles
|
